Literature DB >> 3046767

Plasma cell dyscrasias: current status.

R A Kyle1, P A Greipp.   

Abstract

This is a review of the current status of the monoclonal gammopathies (plasma cell dyscrasias). We begin with the recognition of a monoclonal protein in serum and urine. We briefly discuss the differential diagnosis of the monoclonal gammopathies. Clinical and laboratory findings as well as the management of multiple myeloma are addressed. Future approaches for the treatment of myeloma are provided. The variant forms of multiple myeloma, including smoldering myeloma, plasma cell leukemia, nonsecretory myeloma, IgD myeloma, osteosclerotic myeloma, solitary plasmacytoma of bone, and extramedullary plasmacytoma, are briefly reviewed. Diagnosis and treatment of Waldenström's macroglobulinemia are presented. The recognition and differential diagnosis of the heavy-chain diseases (gamma, alpha, and mu) are included. Monoclonal gammopathy of undetermined significance ("benign" monoclonal gammopathy) is presented in detail. Amyloidosis is not included in this review.

Entities:  

Mesh:

Year:  1988        PMID: 3046767     DOI: 10.1016/s1040-8428(88)80008-8

Source DB:  PubMed          Journal:  Crit Rev Oncol Hematol        ISSN: 1040-8428            Impact factor:   6.312


  6 in total

1.  An unusual presentation of extramedullary plasmacytoma in testis and review of the literature.

Authors:  H Mehmet Turk; Seref Komurcu; Ahmet Ozet; Okan Kuzhan; Omer Günhan
Journal:  Med Oncol       Date:  2009-12-25       Impact factor: 3.064

2.  Hematological malignancies in Al-amal oncology unit, aden.

Authors:  Waiel Al-Kahiry
Journal:  Indian J Hematol Blood Transfus       Date:  2011-08-18       Impact factor: 0.900

Review 3.  Histologic verification of leukemia, myelodysplasia, and multiple myeloma diagnoses in patients in Ukraine, 1987-1998.

Authors:  Irina Dyagil; Mircea Adam; Gilbert W Beebe; J David Burch; Svetlana N Gaidukova; Daniel Gluzman; Natalia Gudzenko; Victor Klimenko; LoAnn Peterson; Robert F Reiss; Stuart C Finch
Journal:  Int J Hematol       Date:  2002-07       Impact factor: 2.490

4.  Presenting signs and symptoms in multiple myeloma: high percentages of stage III among patients without apparent myeloma-associated symptoms.

Authors:  F Ong; J Hermans; E M Noordijk; P W Wijermans; J C Kluin-Nelemans
Journal:  Ann Hematol       Date:  1995-03       Impact factor: 3.673

5.  Is the Durie and Salmon diagnostic classification system for plasma cell dyscrasias still the best choice? Application of three classification systems to a large population-based registry of paraproteinemia and multiple myeloma.

Authors:  F Ong; J Hermans; E M Noordijk; J C Kluin-Nelemans
Journal:  Ann Hematol       Date:  1995-01       Impact factor: 3.673

6.  Clinical and epidemiological features of multiple myeloma patients from a low socio-economic region of Brazil.

Authors:  Carolina Minnicelli; James Farley Rafael Maciel; Rocio Hassan; Telma Maria Araújo Moura Lemos
Journal:  Rev Bras Hematol Hemoter       Date:  2015-07-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.